The Schall Law Firm Seeks Justice for Investors
The Schall Law Firm, a national advocate for shareholders, has embarked on an investigation concerning Outset Medical, Inc. (“Outset” or “the Company”) with the ticker symbol OM on the NASDAQ, citing possible breaches of securities regulations.
Diving into the essence of the inquiry, the focal point is whether the Company disseminated inaccurate or deceptive statements or concealed information crucial to investors. Outset’s disclosure of its second-quarter figures for 2024 on August 7, 2024, painted a grim picture. The Company significantly undershot market forecasts and revised its full-year 2024 projections downward. Stating that the “changes [it] needs to make are entirely in [its] control” and will require “shifts and adjustments” to its sales workforce and processes, Outset witnessed its stock nosedive by a staggering 68.53% on August 8, 2024.
Should you have incurred losses as a shareholder, consider partaking in the investigation by following the provided link.
For those affected, reaching out to Brian Schall at the Schall Law Firm, situated at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, or contacting him directly at 310-301-3335, presents an opportunity to unravel your rights without any financial burden. Communication can also be established via the firm’s website or email address.
The Schall Law Firm extends its support globally, specializing in litigations surrounding securities class actions and shareholder rights.
This press release should be evaluated in the context of Attorney Advertising in select regions, in accordance with relevant laws and ethical standards.
Viewing the original announcement on businesswire.com is highly recommended.